{
    "clinical_study": {
        "@rank": "166530", 
        "acronym": "M192", 
        "arm_group": [
            {
                "arm_group_label": "0% pentose", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Pure sucrose without pentoses added."
            }, 
            {
                "arm_group_label": "4% D-xylose", 
                "arm_group_type": "Active Comparator", 
                "description": "Sucrose drink supplemented with 4% D-xylose"
            }, 
            {
                "arm_group_label": "8% D-xylose", 
                "arm_group_type": "Active Comparator", 
                "description": "Sucrose drink supplemented with 8% D-xylose"
            }, 
            {
                "arm_group_label": "8% L-arabinose", 
                "arm_group_type": "Active Comparator", 
                "description": "Sucrose drink supplemented with 8% L-arabinose"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the effect of L-arabinose and D-xylose in a\n      sugar-rich drink on intestinal sucrase activity in healthy volunteers by measuring\n      postprandial blood glucose and insulin, and selected intestinal hormonal responses to\n      increasing doses of L-arabinose and D-xylose."
        }, 
        "brief_title": "The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man", 
        "completion_date": {
            "#text": "May 2007", 
            "@type": "Actual"
        }, 
        "condition": "Insulin Resistance", 
        "condition_browse": {
            "mesh_term": "Insulin Resistance"
        }, 
        "detailed_description": {
            "textblock": "Based on previous scientific results we hypotesize, that pentoses decreases the demand for\n      insulin in metabolizing a given dose of sucrose."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy males\n\n          -  BMI between 18.4-25 kg/m2\n\n          -  age between 18 and 30\n\n        Exclusion Criteria:\n\n          -  donation of blood 3 months before or during the study\n\n          -  gastrointestinal disorders, diabetes, hypertension, hyperlipidemia, chronic\n             infectious disease (HIV or hepatitis)\n\n          -  smoking\n\n          -  consumption of more than 21 alcoholic drinks/week\n\n          -  elite athletes\n\n          -  on medication"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957098", 
            "org_study_id": "(KF) 11 324909"
        }, 
        "intervention": [
            {
                "arm_group_label": "0% pentose", 
                "description": "14 healthy subjects participated in a randomized double-blinded cross-over study based on four single tests. Sucrose containing drinks were supplemented with two different doses of D-xylose and in addition one dose of L-arabinose was included for comparison with earlier studies. Blood was collected fasting and for 3-h postprandially. Appetite sensations and energy intake were registered. Gastrointestinal symptoms were monitored for 24 hours", 
                "intervention_name": "Placebo comparator: 0% pentose", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "4% D-xylose", 
                "intervention_name": "Active comparator: 4% D-xylose", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "8% D-xylose", 
                "intervention_name": "Active comparator: 8% D-xylose", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "8% L-arabinose", 
                "intervention_name": "Active comparator: 8% L-arabinose", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "L-arabinose", 
            "D-xylose", 
            "sucrose", 
            "glucose", 
            "insulin", 
            "C-peptide", 
            "GLP-1"
        ], 
        "lastchanged_date": "October 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Frederiksberg", 
                    "country": "Denmark", 
                    "zip": "DK-1958"
                }, 
                "name": "Institute of Human Nutrition, The Royal Veterinary and Agricultural University"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "4", 
        "official_title": "The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man", 
        "overall_official": {
            "affiliation": "Department of Nutrition, Exercise and Sports, University of Copenhagen", 
            "last_name": "Jens R Andersen, MD,MPA", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2007", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Level of glucose, insulin, C-peptide and glucagon-like peptide-1 (GLP-1) over time, the area under the curve (AUC), the peak value and time to peak", 
            "measure": "Blood glucose, insulin, C-peptide and GLP-1", 
            "safety_issue": "No", 
            "time_frame": "-15, 0, 15, 30, 45, 60, 90, 120, 180 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957098"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "AAstrup", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Appetite measurements: area under/over the curve (AUC/AOC), 3-h mean. Energy intake: the ad libitum energy intake at lunch was registered. VAS was used to asses the palatability (appearance, smell, taste, after-taste and overall palatability) of the ad libitum lunch.", 
            "measure": "Appetite measurements and energy intake", 
            "safety_issue": "No", 
            "time_frame": "-15, 30, 60, 90, 120, 150 and 180 min"
        }, 
        "source": "University of Copenhagen", 
        "sponsors": {
            "collaborator": {
                "agency": "Danisco", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2006", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}